JP Morgan Chase
BLU

JP Morgan Chase’s BELLUS Health Inc. BLU Stock Holding History

JP Morgan Chase’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-418,416
Closed -$3.01M – 7490
2023
Q1 		$3.01M Buy
418,416
+59,854
+17% +$464K ﹤0.01% 3229
2022
Q4 		$2.95M Sell
358,562
-173,017
-33% -$1.61M ﹤0.01% 3254
2022
Q3 		$5.61M Sell
531,579
-385,336
-42% -$4.1M ﹤0.01% 2643
2022
Q2 		$8.47M Sell
916,915
-242,818
-21% -$1.99M ﹤0.01% 2302
2022
Q1 		$7.98M Buy
1,159,733
+648,068
+127% +$4.17M ﹤0.01% 2599
2021
Q4 		$4.12M Sell
511,665
-447,761
-47% -$2.97M ﹤0.01% 3230
2021
Q3 		$5.89M Buy
+959,426
New +$3.64M ﹤0.01% 2898
2020
Q2 		– Sell
-29,438
Closed -$294K – 5804
2020
Q1 		$294K Sell
29,438
-48,156
-62% -$429K ﹤0.01% 4101
2019
Q4 		$590K Buy
77,594
+15,000
+24% +$103K ﹤0.01% 4158
2019
Q3 		$400K Buy
+62,594
New +$442K ﹤0.01% 4276

Other funds holding BLU

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.32B AUM 51.82% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

JP Morgan Chase's BLU Position: Q2 2023 in Review

JP Morgan Chase sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 418,416 shares — an estimated $3.01M sold.

JP Morgan Chase first reported a position in BLU in Q3 2019 and held it in 10 quarters. The position peaked at $8.47M in Q2 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • JP Morgan Chase reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • JP Morgan Chase sold 418,416 BELLUS Health Inc. shares in Q2 2023, an estimated $3.01M.
  • JP Morgan Chase first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 10 quarters.
  • JP Morgan Chase's BELLUS Health Inc. position peaked at $8.47M in Q2 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.